Oncological Mastectomy in the Context of Reaffirmation of Sex in a Male Transgender Patient: Case Report and Literature Review Oncological Mastectomy in Transgender Patient

Pablo Sciuto (1), Lucía Romero (2), Andrea Cristiani (3), Daniel González (4)
(1) Surgical Clinic´´ ´´3´´ University of the Republic. Associate Professor of Surgery. Specialist in Mastology. Uruguay, Uruguay,
(2) Surgical Clinic ´´3´´. University of the Republic. Surgical Resident. Uruguay, Uruguay,
(3) Pathological Anatomy Chair. University of the Republic. Associate Professor. Pathologist. Uruguay, Uruguay,
(4) Surgical Clinic ´´3´´ University of the Republic. Professor of Surgery. Uruguay, Uruguay

Abstract

Background: Breast cancer in the male transgender patient is a great challenge for the medical team, because it is completely different from the usual clinical scenario and there is a lack of scientific knowledge and protocols for managing this special medical situation.


Case presentation: We present a 32-year-old transmasculine patient, who developed a palpable nodule on the left breast during the androgen hormonal treatment. Imaging showed a BIRADS5 nodule and core biopsy detected a luminal B breast invasive carcinoma (IDC) with androgen receptor expression.  He underwent a gender reaffirmation oncological mastectomy, chemotherapy and hormonal therapy.


Conclusion: In the transgender male scenario, the surgical technique should take into consideration the patient’s aesthetical desire and the oncological result. In this context, it is controversial if the hormonal and oncological therapies should also be changed.

Full text article

Generated from XML file

References

Winter S, Diamond M, Green J, Karasic D, Reed T, Whittle S, et al. Transgender people: health at the margins of society. The Lancet. 2016;388(10042):390-400. DOI: 10.1016/s0140-6736(16)00683-8.

Flores AR HJ, Gates et al. How Many Adults Identify as Transgender in the United States? . 2016. Available from: https://williamsinstitute.law.ucla.edu/wp-content/uploads/Trans-Adults-US-Aug-2016.pdf

Coleman E, Bockting W, Botzer M, Cohen-Kettenis P, DeCuypere G, Feldman J, et al. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7. International Journal of Transgenderism. 2012;13(4):165-232. doi: 10.1080/15532739.2011.700873.

Brettes JP MC. Dual effects of androgens on mammary gland. Bull Cancer. 2008;95:495-502. doi: 10.1684/bdc.2008.0631.

Gooren L vTM, Giltay EJ, et al. Breast cancer development in transexual subjects receiving cross-sex hormone treatment. J Sex Med. 2013;10:3129-34. doi: 10.1111/jsm.12319.

Brown GR, Jones KT. Incidence of breast cancer in a cohort of 5,135 transgender veterans. Breast Cancer Res Treat. 2015;149(1):191-8. doi: 10.1007/s10549-014-3213-2.

de Blok CJM, Wiepjes CM, Nota NM, van Engelen K, Adank MA, Dreijerink KMA, et al. Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands. Bmj. 2019;365:l1652. doi: 10.1136/bmj.l1652.

Stone JP, Hartley RL, Temple-Oberle C. Breast cancer in transgender patients: A systematic review. Part 2: Female to Male. Eur J Surg Oncol. 2018;44(10):1463-8. doi: 10.1016/j.ejso.2018.06.021.

Joint R, Chen ZE, Cameron S. Breast and reproductive cancers in the transgender population: a systematic review. Bjog. 2018;125(12):1505-12. doi: 10.1111/1471-0528.15258.

Eismann J, Heng YJ, Fleischmann-Rose K, Tobias AM, Phillips J, Wulf GM, et al. Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature. Clin Breast Cancer. 2019;19(1):e12-e9. doi: 10.1016/j.clbc.2018.11.007.

Kopetti C, Schaffer C, Zaman K, Liapi A, di Summa PG, Bauquis O. Invasive Breast Cancer in a Trans Man After Bilateral Mastectomy: Case Report and Literature Review. Clin Breast Cancer. 2021;21(3):e154-e7. doi: 10.1016/j.clbc.2020.10.005.

Alaofi RK, Nassif MO, Al-Hajeili MR. Prophylactic mastectomy for the prevention of breast cancer: Review of the literature. Avicenna J Med. 2018;8(3):67-77. doi: 10.4103/ajm.AJM_21_18.

Gooren L, Bowers M, Lips P, Konings IR. Five new cases of breast cancer in transsexual persons. Andrologia. 2015;47(10):1202-5. doi: 10.1111/and.12399.

Burcombe RJ, Makris A, Pittam M, Finer N. Breast cancer after bilateral subcutaneous mastectomy in a female-to-male trans-sexual. Breast. 2003;12(4):290-3. doi: 10.1016/s0960-9776(03)00033-x.

Wolf Y, Kwartin S. Classification of Transgender Man's Breast for Optimizing Chest Masculinizing Gender-affirming Surgery. Plast Reconstr Surg Glob Open. 2021;9(1):e3363. doi: 10.1097/gox.0000000000003363.

Hickey TE, Selth LA, Chia KM, Laven-Law G, Milioli HH, Roden D, et al. The androgen receptor is a tumor suppressor in estrogen receptor-positive breast cancer. Nat Med. 2021;27(2):310-20. doi: 10.1038/s41591-020-01168-7.

Fledderus AC, Gout HA, Ogilvie AC, van Loenen DKG. Breast malignancy in female-to-male transsexuals: systematic review, case report, and recommendations for screening. Breast. 2020;53:92-100. doi: 10.1016/j.breast.2020.06.008.

Authors

Pablo Sciuto
sciutopablo@hotmail.com (Primary Contact)
Lucía Romero
Andrea Cristiani
Daniel González
1.
Sciuto P, Romero L, Cristiani A, González D. Oncological Mastectomy in the Context of Reaffirmation of Sex in a Male Transgender Patient: Case Report and Literature Review: Oncological Mastectomy in Transgender Patient. Arch Breast Cancer [Internet]. 2022 Apr. 16 [cited 2024 Feb. 22];9(3):401-6. Available from: https://archbreastcancer.com/index.php/abc/article/view/566

Article Details